Haemonetics: Q2 Earnings Insights

Haemonetics HAE reported its Q2 earnings results on Monday, November 7, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Haemonetics beat estimated earnings by 23.88%, reporting an EPS of $0.83 versus an estimate of $0.67.

Revenue was up $57.59 million from the same period last year.

Last quarter the company beat on EPS by $0.07 which was followed by a 0.72% drop in the share price the next day.

Here's a look at Haemonetics's past performance:

Quarter	Q1 2023	Q4 2022	Q3 2022	Q2 2022
EPS Estimate	0.51	0.60	0.73	0.61
EPS Actual	0.58	0.65	0.84	0.60
Revenue Estimate	249.00M	257.82M	266.74M	241.40M
Revenue Actual	261.46M	265.00M	259.77M	239.90M

To track all earnings releases for Haemonetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-Recaps Earnings